/ Print /

  • linkedin
  • Increase Font
  • Sharebar

    What oncologists say about new cancer treatment options


    Community oncologists play an integral role in patient referral and adoption of new treatment options for cancer, according to a new report.

    These treatment options include CAR T-cell therapies, genomic medicines, and biosimilars, according to Cardinal Health Specialty Solutions’ Oncology Insights, a research report that provides insights into oncologists’ perspectives on these treatment advances, potential barriers to adoption, and how treatment trends are changing.

    NabhanNabhan“As we move toward a value-based care environment and more emphasis is put on lowering cost of care, managed care executives will be faced with challenging reimbursement decisions such as when to approve reimbursement for innovative therapies like CAR T and whether to mandate the use of biosimilars in place of branded biologics to reduce costs,” says Chadi Nabhan, MD, MBA, FACP, chief medical officer, Cardinal Health Specialty Solutions. “Understanding how the views and behaviors of providers are changing in this complex and dynamic market may help managed care leaders make more informed decisions.”

    Key findings of the report include:

    • Most oncologists (51%) see CAR T-cell therapy as a game-changing approach to cancer treatment, but barriers such as cost, toxicity, and complex administration could lead to slow uptake.
    • As more biosimilars enter the U.S. market, oncologists are open to prescribing them in place of their reference products, and most (66%) have high expectations about the cost savings biosimilars will deliver for their practices.
    • With three targeted therapies recently approved for acute myeloid leukemia (AML), most oncologists (85%) are routinely prescribing genetic tests for AML patients—and a growing number (31%) are now referring AML patients to academic medical centers for treatment.

    Based on the findings, Bruce Feinberg, DO, vice president, chief medical officer, Cardinal Health Specialty Solutions, offers these three recommendations for healthcare executives: 

    FeinbergFeinberg1.     Be an advocate for more research on total cost of care. “The emergence of innovative new drugs for diseases like AML will have significant implications on cost of care, beyond just comparison of drug prices,” Feinberg says. “Longitudinal studies are needed to better understand total cost of treatment over time. This research will help both providers and payers make informed decisions.”

    2.     Become a sponsor of real-world evidence research.  Real-world evidence research has become more sophisticated and more widely accepted as a critical tool for gaining insights into comparative effectiveness and resource utilization, according to Feinberg. “There will be an increased need for it as more biosimilars come to market,” he says. “By stepping up to sponsor real-world evidence research, payers can play an important role in facilitating better treatment decisions.”

    3.     Maintain open dialogue with healthcare providers and drug manufacturers.  “As novel new therapies come to market at a rapid pace, candid discussions between key stakeholders are needed to move the industry toward higher quality care at a lower cost,” he says. 




    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • [email protected]
      I had chronic obstructive pulmonary disease (COPD) for 15 years. My first symptoms were dry cough, chest tightness and shortness of breath. My first chest x-ray only showed bronchitis. Finally I went to a pulmonologist, After many tests it was a CT scan that showed COPD, and scarring in my lungs. I quit smoking 17 years and 6 months ago. But the damage has been done. I got to the point I couldn't catch my breath and was coughing so hard I thought the top of my head would blow off. The day after I had the scan I was on oxygen the next night and was on it 24/7. December 2017 my pulmonologist and I decided to go with natural treatment and was introduced to Mbeki Herbal Clinic natural organic COPD Herbal formula, i had a total decline of symptoms with this COPD Herbal formula treatment. The infections, shortness of breath, fatigue, dry cough and other symptoms has subsided. Visit Mbeki Herbal Clinic official website ww w. mbekiherbalclinic. com or email [email protected] mbekiherbalclinic. com. I have had great improvement with my over all respiration with this product and i breath very much easier, i can never be thankful enough to nature
    • [email protected]
      Chloe Ryan My dad was diagnosed with ALS. He does not have ALS anymore.ALS herbal remedies i purchased online from Dr Lauren (Good Health Herbs Home) cured my day ALS .pleases anyone out there with ALS,natural herbal remedy is the real things to use, No more toxic medication that clearly state 'lead to death'. Let real and natural herbal remedy be your medicine. Stay away from vaccines and frankenfood.contact Dr Lauren for your ALS cure, website ww w goodhealthherbshome com

    Follow Us On Twitter

    Find us on Facebook

    Latest Tweets Follow